Eckert, C <br/><br/>
Comparison between TaqMan and LightCycler technologies for quantification of minimal residual disease by using immunoglobulin and T-cell receptor genes consensus probes.  [electronic resource] 

 -  Leukemia  Dec 2003 
 - 2517-24 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0887-6924 
<br/><br/><label>Standard No.: </label>10.1038/sj.leu.2403103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>DNA Probes<br/>Gene Rearrangement, T-Lymphocyte--genetics<br/>Humans<br/>Immunoglobulins--genetics<br/>Leukemia--diagnosis<br/>Linear Models<br/>Neoplasm, Residual--diagnosis<br/>Nucleic Acid Hybridization<br/>Polymerase Chain Reaction--methods<br/>Receptors, Antigen, T-Cell--genetics<br/>Sensitivity and Specificity<br/>Taq Polymerase